Wednesday, August 3, 2011

Actos (Pioglitazone HCl) which is marketed as Actos, Actoplus Met®, and Duetact®, was reported to be linked to an increased incidence of BLADDER CANCER according to the FDA Safety announcement of September 17th.

While the ten year study did not show an absolute link between all taking Actos and bladder cancer, an increased risk of bladder cancer was observed among patients with the longest exposure to Actos, as well as in those exposed to the highest cumulative dose of Actos.

If you believe you have been affected by Actos and you need assistance with filing an actos lawsuit or want to be involved in any possible settlement, you can speak with someone now who is experienced with the tragedy of drugs that harmed when they were meant to heal.

No comments:

Post a Comment